Support our Foundation of Myology project
1722 news items
Liver damage in myotubular myopathy
On 27/12/2021
Hepatobiliary involvement, such as gallstones or peliosis hepatis, has been reported in several cases of myotubular myopathy since the 1990s. It was found in 7%…
MADD deficiency is particularly common in China and responds to vitamin therapy
On 27/12/2021
Multiple acyl-CoA dehydrogenase (MADD) deficiency is a rare inherited disease affecting fatty acid oxidation. It can result, in its late onset form, by a muscle…
McArdle disease phenotype description enriched with muscle imaging data
On 24/12/2021
Fifteen adults aged 25 to 80 with McArdle myopathy, a metabolic neuromuscular disease caused by myophosphorylase deficiency, underwent muscle imaging examinations at the Garches Reference…
Clinical outcomes of two new generation enzyme therapies in Pompe disease
On 23/12/2021
• The results of two phase III clinical trials evaluating new-generation double-blind enzyme therapies in late-onset Pompe disease against Myozyme were published in December 2021. •…
A natural history study in a population of children with FSHD
On 22/12/2021
Dutch specialists were interested in 20 patients with facio-scapulo-humeral myopathy (FSH) aged between 2 and 17 years. Among them were patients with the infantile form…
Hereditary neuropathy with TFP protein deficiency responds to specific treatment
On 21/12/2021
Chinese clinicians report the observation of a 29-year-old female patient with a childhood motor deficit in the lower limbs labeled Charcot-Marie-Tooth disease (CMT). The EMG…
MYOLOGY 2022 – sept. 12-15 & mitoNice – sept. 15-17
On 20/12/2021
Save the date! The MYOLOGY 2022 international congress, organized by the AFM-Téléthon, will be held from September 12 to 15, 2022 in Nice and will…
Advances in the pathophysiology of myoglobinopathy
On 20/12/2021
Myoglobinopathy is an ultra-rare autosomal dominant neuromuscular disease first described in 2019 and caused by a His98Tyr mutation in the MB gene that encodes myoglobin.…
The Myomex trial confirms the interest of the prescription of mexiletine in non-dystrophic myotonias
On 17/12/2021
The Myomex trial, conducted by the AP-HP (the Paris public hospital system) and supported by AFM-Téléthon, evaluated the efficacy and safety versus placebo of a…
Norwegian study clarifies clinical profile of chronic forms of juvenile dermatomyositis
On 16/12/2021
Chronic forms of juvenile dermatomyositis (JDM) represent a therapeutic challenge. Norwegian clinicians studied a cohort of 59 patients with JDM which they compared to a…
Muscle damage in women transmitting DMD / DMB more common than expected
On 16/12/2021
• A cross-sectional study of 53 women with pathological abnormalities of the DMD gene, leading to either DMD (33/53) or BMD (20/53) showed: signs of…
Next-generation sequencing of mummified remains of 14th century Italian nobleman detects first known case of Pompe disease
On 16/12/2021
Science can sometimes solve historical puzzles, such as the one surrounding the death of Alberto Canfrancesco della Scala, Lord of Verona and protector of Dante.…
A meta-analysis highlights the superiority of deflazacort in DMD
On 15/12/2021
Glucocorticoids are the standard treatment for Duchenne muscular dystrophy (DMD). There is no consensus on the type of steroid and the method of administration (doses,…
Nusinersen in real life in the United States: a study highlights the difficulties of compliance
On 15/12/2021
Nusinersen is an antisense oligonucleotide that has been used in the treatment of SMA since 2016. Its method of administration (intrathecal) and the need for…
Publication of the results of the PLEO-CMT trial evaluating the PXT3003 in CMT1A
On 14/12/2021
• PXT3003 is a low dose combination of baclofen, naltrexone and sorbitol which is believed to act synergistically to inhibit the excessive expression of PMP22…
Mechanisms and future treatments for myasthenia gravis debated at International Society of Neuroimmunology (ISNI) congress
On 14/12/2021
Supported by AFM-Telethon, the 15th edition of the International Society of Neuro-immunology congress was held online from November 8 to 12, 2021. It was co-chaired…
Autoimmune neurological complications after Covid-19 vaccination remain exceptional
On 13/12/2021
German specialists have identified 21 autoimmune neurological complications in their respective canton that occurred between March 1 and June 1, 2021 after Covid-19 vaccination in…
Early muscle damage in Glycogenosis type IIIa
On 09/12/2021
Glycogenosis type IIIa is a deficiency in a debranching enzyme. It initially results in hepatic disorders but can classically lead to muscle disorders and increased…
ERN EURO-NMD webinar, December 16th : Profs Tracey Willis & Derek Willis (UK)
On 09/12/2021
Palliative care in Neuromuscular Disorders Thursday December 16th, 2021 – 4pm-5pm (Paris time) Prof. Tracey Willis (Robert Jones and Agnes Hunt Orthopaedic and District Hospital…
Continuous non-invasive ventilation may be an alternative to tracheostomy ventilation
On 08/12/2021
A significant number of neuromuscular patients with severe respiratory impairment are ventilated invasively, most often by means of a tracheostomy. An international study compiled data…
